Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Digital Pathology Market, by Product
1.4.2 Europe Digital Pathology Market, by End Use
1.4.3 Europe Digital Pathology Market, by Application
1.4.4 Europe Digital Pathology Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Approvals
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct – 2021, Feb) Leading Players
Chapter 4. Europe Digital Pathology Market by Product
4.1 Europe Device Market by Country
4.2 Europe Software Market by Country
4.3 Europe Storage System Market by Country
Chapter 5. Europe Digital Pathology Market by End-use
5.1 Europe Hospitals Market by Country
5.2 Europe Diagnostic Labs Market by Country
5.3 Europe Biotech & pharma companies Market by Country
5.4 Europe Academic & research institutes Market by Country
Chapter 6. Europe Digital Pathology Market by Application
6.1 Europe Drug Discovery & Development Market by Country
6.2 Europe Disease Diagnosis Market by Country
6.3 Europe Academic research Market by Country
Chapter 7. Europe Digital Pathology Market by Country
7.1 Germany Digital Pathology Market
7.1.1 Germany Digital Pathology Market by Product
7.1.2 Germany Digital Pathology Market by End-use
7.1.3 Germany Digital Pathology Market by Application
7.2 UK Digital Pathology Market
7.2.1 UK Digital Pathology Market by Product
7.2.2 UK Digital Pathology Market by End-use
7.2.3 UK Digital Pathology Market by Application
7.3 France Digital Pathology Market
7.3.1 France Digital Pathology Market by Product
7.3.2 France Digital Pathology Market by End-use
7.3.3 France Digital Pathology Market by Application
7.4 Russia Digital Pathology Market
7.4.1 Russia Digital Pathology Market by Product
7.4.2 Russia Digital Pathology Market by End-use
7.4.3 Russia Digital Pathology Market by Application
7.5 Spain Digital Pathology Market
7.5.1 Spain Digital Pathology Market by Product
7.5.2 Spain Digital Pathology Market by End-use
7.5.3 Spain Digital Pathology Market by Application
7.6 Italy Digital Pathology Market
7.6.1 Italy Digital Pathology Market by Product
7.6.2 Italy Digital Pathology Market by End-use
7.6.3 Italy Digital Pathology Market by Application
7.7 Rest of Europe Digital Pathology Market
7.7.1 Rest of Europe Digital Pathology Market by Product
7.7.2 Rest of Europe Digital Pathology Market by End-use
7.7.3 Rest of Europe Digital Pathology Market by Application
Chapter 8. Company Profiles
8.1 Danaher Corporation (Leica Biosystems)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental &Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.2 Koninklijke Philips N.V.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Olympus Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 ContextVision AB
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Approvals:
8.6 Hamamatsu Photonics K.K.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.7 Mikroscan Technologies, Inc.
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 Inspirata, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Acquisition and Mergers:
8.9 Visiopharm A/S
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.9.2.2 Product Launches and Product Expansions:
8.9.2.3 Acquisition and Mergers:
8.10. 3DHISTECH Ltd.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
Unique Offerings 
